4 European Projects Found
Searched on 125080 European Projects
FINISHED
RELapses prevENTion in chronic autoimmune disease: common mechanisms and co-morbidities (RELENT)
Start date: Nov 1, 2015, End date: Apr 30, 2020,
RELENT is multidisciplinary group of scientists and clinical investigators whose goal is to develop individualized treatment for chronic autoimmune diseases, such as rheumatoid arthritis and vasculitis, that cause considerable mortality and morbidity, both from uncontrolled disease and treatment associated co-morbidities, like infection and malignancy. This requires the need to stratify patients b ...
Read Project
14
Partners Participants
FINISHED
Disarming the intravascular innate immune response to improve treatment modalities for chronic kidney disease (DIREKT)
Start date: Dec 1, 2013, End date: Nov 30, 2017,
"Chronic kidney disease is world wide a major cause of end-stage renal disease (ESRD). 800.000 patients in Europe and in the US, respectively, require long-term treatment initially with peritoneal dialysis, followed by hemodialysis and kidney transplantation. Each ESRD patient on hemodialysis costs ≈€40000 to €80000 per year, has extremely poor quality of life and an average life expectancy of onl ...
Read Project
12
Partners Participants
FINISHED
Infectious triggers of chronic autoimmunity (INTRICATE)
Start date: Nov 1, 2010, End date: Apr 30, 2015,
This proposal builds on existing expertise and collaborations of a multidisciplinary Consortium of basic scientists and clinical investigators each of whom has made a substantial individual contribution to understanding the links between infection and autoimmunity. The aim of the INTRICATE Consortium is to prosecute a programme of Translational Research that deliniates the role of infection in the ...
Read Project
13
Partners Participants
FINISHED
Translational Science for Vascular Inflammation and Remodelling (TranSVIR)
Start date: Dec 1, 2009, End date: Nov 30, 2013,
The rapid advance of biology is providing new insights into the causes of some of today’s most pressing medical problems as well as huge opportunities to develop and evaluate novel and more effective treatments. The challenge is to exploit these advances effectively and this will require a new breed of translational scientist with expertise in a specific discipline coupled with a broad understandi ...
Read Project
